An international study revealed an increasing trend in the use of molecular testing for diagnosing thyroid nodules from 2019 to 2022 ( 86 ), which accounted for only < 10%.
← all excerpts
Ultrasound radiomics and genomics improve the diagnosis of cytologically indeterminate thyroid nodules.
1
—
—